Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells
出版年份 2023 全文链接
标题
Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells
作者
关键词
-
出版物
Nanomedicine-Nanotechnology Biology and Medicine
Volume 54, Issue -, Pages 102710
出版商
Elsevier BV
发表日期
2023-09-20
DOI
10.1016/j.nano.2023.102710
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells
- (2022) Valeria Unida et al. Pharmaceutics
- Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures
- (2021) Sofia Raniolo et al. Cell Death & Disease
- DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery
- (2021) Aurélie Lacroix et al. ACS Nano
- The Role of Early Growth Response Family Members 1–4 in Prognostic Value of Breast Cancer
- (2021) Leiyu Hao et al. Frontiers in Genetics
- AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy
- (2021) Giulia Vindigni et al. Pharmaceutics
- Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets
- (2020) Emily M. Murphy et al. PLoS One
- LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis
- (2020) Niansheng Ren et al. Aging-US
- Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells
- (2020) Steffen K. Meurer et al. CELLULAR SIGNALLING
- Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer
- (2020) Hui-Chen Ku et al. Frontiers in Endocrinology
- Designer DNA nanostructures for therapeutics
- (2020) Shuoxing Jiang et al. Chem
- SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3
- (2019) Yanbing Chen et al. EXPERIMENTAL CELL RESEARCH
- LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis
- (2019) Er-lin Song et al. Aging-US
- MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma
- (2019) Adèle Mangelinck et al. Scientific Reports
- Mutation of the PTCH1 gene predicts recurrence of breast cancer
- (2019) Chih-Yang Wang et al. Scientific Reports
- In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing
- (2019) Sofia Raniolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages
- (2018) Sofia Raniolo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors
- (2018) Sofia Raniolo et al. Nanoscale
- Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
- (2018) Austin Yeon et al. Theranostics
- A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
- (2017) Fangfei Li et al. Nature Communications
- Receptor-Mediated Entry of Pristine Octahedral DNA Nanocages in Mammalian Cells
- (2016) Giulia Vindigni et al. ACS Nano
- DNA nanovehicles and the biological barriers
- (2016) Anders H. Okholm et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- Wnt5a Signaling in Cancer
- (2016) Marwa Asem et al. Cancers
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
- (2013) N Habel et al. Cell Death & Disease
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Arsenic Trioxide (ATO) Influences the Gene Expression of Metallothioneins in Human Glioblastoma Cells
- (2012) Ingrid Falnoga et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Proteomic Analysis of Glioma Chemoresistance
- (2012) Kyoungho Suk Current Neuropharmacology
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Structure of Nanoscale Truncated Octahedral DNA Cages: Variation of Single-Stranded Linker Regions and Influence on Assembly Yields
- (2010) Cristiano Luis Pinto Oliveira et al. ACS Nano
- Deciphering the Structural Properties That Confer Stability to a DNA Nanocage
- (2009) Mattia Falconi et al. ACS Nano
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells
- (2009) Long Tai Zheng et al. JOURNAL OF NEUROCHEMISTRY
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Over-expression of metallothionein predicts chemoresistance in breast cancer
- (2008) Xinli Yap et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started